EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 38 / No 6-7 (Juin–Juillet 2022) Med Sci (Paris), 38 6-7 (2022) 553-561 References
Open Access
Issue
Med Sci (Paris)
Volume 38, Number 6-7, Juin–Juillet 2022
Page(s) 553 - 561
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2022081
Published online 29 June 2022
  1. Zhang SY, Jouanguy E, Zhang Q, et al. Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. Curr Opin Immunol 2019 ; 59 : 88–100. [Google Scholar]
  2. Dawson R.Cellular Inclusions in Cerebral Lesions of Lethargic Encephalitis. Am J Pathol 1933 ; 9 : 7–163. [Google Scholar]
  3. van Bogaert L.Une leuco-encéphalite sclérosante subaiguë. J Neurol Neurosurg Psychiatry 1945 ; 8 : 101–120. [Google Scholar]
  4. Bouteille M, Fontaine C, Vedrenne CSur un cas d’encephalite subaiguë à inclusions. Etude anatomoclinique et ultrastructurale. Rev neurol 1965 ; 113 : 454–458. [Google Scholar]
  5. Connolly JH, Allen IV, Hurwitz LJ, Millar JHSubacute sclerosing panencephalitis. Clinical, pathological, epidemiological, and virological findings in three patients. Q J Med 1968 ; 37 : 625–644. [PubMed] [Google Scholar]
  6. Baublis JV, Payne FEMeasles antigen and syncytium formtion in brain cell cultures from subacute sclerosing panencephalitis (SSPE). Proc Soc Exp Biol Med 1968 ; 129 : 593–597. [Google Scholar]
  7. Satoh Y, Higuchi K, Nishikawa D, et al. M protein of subacute sclerosing panencephalitis virus, synergistically with the F protein, plays a crucial role in viral neuropathogenicity. J Gen Virol 2021; 102 : 001682. [Google Scholar]
  8. Ayata M, Takeuchi K, Takeda M, et al. The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence. J Virol 2010 ; 84 : 11189–11199. [Google Scholar]
  9. Lebon P, Gelot A, Zhang SY, et al. Measles Sclerosing Subacute PanEncephalitis (SSPE), an intriguing and ever-present disease: Data, assumptions and new perspectives. Rev Neurol (Paris) 2021; 177 : 1059–68. [Google Scholar]
  10. Mathieu C, Bovier FT, Ferren M, et al. Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain. mBio 2021; 12 : e0079921. [Google Scholar]
  11. Gutierrez J, Issacson R, Koppel BSSubacute sclerosing panencephalitis: an update. Dev Med Child Neurol 2010 ; 52 : 901–907. [Google Scholar]
  12. Saha V, John TJ, Mukundan P, et al. High incidence of subacute sclerosing panencephalitis in south India. Epidemiol Infect 1990 ; 104 : 151–156. [Google Scholar]
  13. Lucas KM, Sanders RC, Rongap A, et al. Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children. Epidemiol Infect 1992 ; 108 : 547–553. [Google Scholar]
  14. Mekki M, Eley B, Hardie D, Wilmshurst JMSubacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions. Dev Med Child Neurol 2019 ; 61 : 1139–1144. [Google Scholar]
  15. Rebière I, Drucker JEpidemiological surveillance of measles in France. Santé 1994 ; 4 : 189–190. [Google Scholar]
  16. Mitus MA, Holloway HA, Evans AE, Enders JFAttenuated measles vaccine in children with acute leukemia. Am J Dis Child 1962 ; 103 : 413–418. [PubMed] [Google Scholar]
  17. Bitnun A, Shannon P, Durward A, et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis 1999 ; 29 : 855–861. [Google Scholar]
  18. Duncan CJ, Mohamad SM, Young DF, et al. Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med 2015 30; 7 : 307ra154. [Google Scholar]
  19. Aicardi J, Goutieres F, Arsenio-Nunes ML, Lebon PAcute measles encephalitis in children with immunosuppression. Pediatrics 1977 ; 59 : 232–239. [Google Scholar]
  20. Prashanth LK, Taly AB, Sinha S, Ravi VSubacute sclerosing panencephalitis (SSPE): an insight into the diagnostic errors from a tertiary care university hospital. J Child Neurol 2007 ; 22 : 683–688. [Google Scholar]
  21. Bonifas-Galup P, Hamano KC, Sebrosa J, et al. Different clinical and electroencephalographic aspects of subacute sclerosing panencephalitis (SSPE). A propos of 51 cases. Rev Electroencephalogr Neurophysiol Clin 1983 ; 13 : 224–231. [Google Scholar]
  22. Chabrol B, Mancini J, Dulac O, et al. Neurologie pédiatrique 2010 ; 3third editionParisM-S Flammarion Lavoisierp403–p494. [Google Scholar]
  23. Häusler M, Aksoy A, Alber M, et al. A Multinational Survey on Actual Diagnostics and Treatment of Subacute Sclerosing Panencephalitis. Neuropediatrics 2015 ; 46 : 377–384. [Google Scholar]
  24. Radermecker J.Clinical and electroencephalographic aspects of subacute sclerosing leukoencephalitis. Rev Neurol (Paris) 1951 ; 84 : 680–684. [PubMed] [Google Scholar]
  25. Prasad C, Netravathi M, Kulanthaivelu K, et al. Subacute Sclerosing Panencephalitis: Restricted Diffusion and Clinical Evolution. Neurol India 2022; 70 : 275–80. [PubMed] [Google Scholar]
  26. Lebon P, Chany C, Turpin JCDemonstration of antibodies precipitating an antigen of Carrés disease virus in the serum of patients with LESS. C R, Acad Hebd Seances Acad Sci D 1972 ; 274 : 1757–1760. [Google Scholar]
  27. Ziola B, Salmi A, Panelius M, Halonen P. Measles virus-specific IgM antibodies and IgM-class rheumatoid factor in serum and cerebrospinal fluid of subacute sclerosing panencephalitis patients. Clin Immunol Immunopathol 1979 ; 13 : 462–474. [Google Scholar]
  28. Loirat C, Danon F, Broyer MSubacute sclerosing panencephalitis appearing during nephrotic syndrome treated with immunosuppressive agents. Arch Fr Pediatr 1971 ; 28 : 1083–1091. [PubMed] [Google Scholar]
  29. Lebon P, Freymuth FVirus de la rougeole : immunodépression, diagnostic. Médecine thérapeutique/pédiatrie 2010 ; 13 : 343–352. [Google Scholar]
  30. Pons JC, Lebon P, Frydman R, Delfraissy JFPharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal Diagn Ther 1995 ; 10 : 7–10. [Google Scholar]
  31. Sawaishi Y, Abe T, Yano T, Ishikawa K, Takada GSSPE following neonatal measles infection. Pediatr Neurol 1999 ; 20 : 63–65. [Google Scholar]
  32. Krivine A, Force G, Servan J, et al. Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex. J Neurovirol 1999 ; 5 : 500–506. [Google Scholar]
  33. Cavlek TV, Sternak SL, Kaic B, et al. Subacute sclerosing panencephalitis in Croatia (1994–2004). Acta Microbiol Immunol Hung 2007 ; 54 : 57–63. [Google Scholar]
  34. Comert S, Vitrinel A, Alper Gursu H, et al. Subacute sclerosing panencephalitis presenting as acute disseminated encephalomyelitis. Indian J Pediatr 2006 ; 73 : 1119–1121. [Google Scholar]
  35. Lackmann GM, Hannen M, Madjlessi F, et al. Rapid progressive subacute sclerosing panencephalitis in a 2-year-old child with congenital athyreosis. Clin Infect Dis 2000 ; 31 : 196–199. [Google Scholar]
  36. Oldstone MB, Dales S, Tishon A, et al. Role for dual viral hits in causation of subacute sclerosing panencephalitis. J Exp Med 2005 ; 202 : 1185–1190. [Google Scholar]
  37. Lyon G, Ponsot G, Lebon PAcute measles encephalitis of the delayed type. Ann Neurol 1977 ; 2 : 322–327. [Google Scholar]
  38. Ponsot G, Lebon P, Lyon GAcute delayed measles encephalitis. J Neurol Sci 1978 ; 39 : 99–109. [Google Scholar]
  39. Aulakh R, Tiwari ASubacute sclerosing panencephalitis in a toddler: changing epidemiological trends. Case Rep Pediatr 2013 ; 2013 : 341462. [PubMed] [Google Scholar]
  40. Coulter JB, Balch N, Best PVSubacute sclerosing panencephalitis after drug-induced immunosuppression. Arch Dis Child 1979 ; 54 : 640–642. [Google Scholar]
  41. Fukuya H, Ohfu M, Tomoda Y, et al. A case of subacute sclerosing panencephalitis developing 8 years after immunosuppressive treatment for acute lymphocytic leukemia. No To Hattatsu 1992 ; 24 : 60–64. [PubMed] [Google Scholar]
  42. Garg RK, Sharma PK, Kumar N, Pandey S. Subacute Sclerosing Panencephalitis in Older Adulthood. Tremor Other Hyperkinet Mov (N Y) 2019; 9. [Google Scholar]
  43. Klenerman P, Hengartner H, Zinkernagel RMA non-retroviral RNA virus persists in DNA form. Nature 1997 ; 390 : 298. [Google Scholar]
  44. Moulias RL, Reinert P, Goust JMImmunologic abnormalities in subacute sclerosing panencephalitis. N Engl J Med 1971 ; 285 : 1090. [PubMed] [Google Scholar]
  45. Lebon P, Schuller E, JD Degos JD, et al. CSF alpha and gamma interferons in acute and subacute and multiple sclerosis: comparative study. Cellular and humoral immunological components of cerebrospinal fluid in multiple sclerosis. In: Cellular and Humoral immunological components of cerebrospinal fluid in multiple sclerosis. Ed. A Lowenthal and J. Raus. Paris: Plenum Press, 1986 : 429–436. [Google Scholar]
  46. Gadoth N, Kott E, Levin S, Hahn TThe interferon system in subacute sclerosing panencephalitis and its response to isoprinosine. Brain Dev 1989 ; 11 : 308–312. [Google Scholar]
  47. Lebon P, Boutin B, Dulac O, et al. Interferon gamma in acute and subacute encephalitis. Br Med J 1988 ; 296 : 9–11. [Google Scholar]
  48. Schuller E, Delasnerie N, Lebon PDNA and RNA antibodies in serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients. J Neurol Sci 1978 ; 37 : 31–36. [Google Scholar]
  49. Joncas JH, Robillard LR, Boudreault A, et al. Letter: Interferon in serum and cerebrospinal fluid in subacute sclerosing panencephalitis. Can Med Assoc J 1976 ; 115 : 309. [PubMed] [Google Scholar]
  50. Ogata S, Ogata A, Schneider-Schaulies S, Schneider-Schaulies JExpression of the interferon-alpha/beta-inducible MxA protein in brain lesions of subacute sclerosing panencephalitis. J Neurol Sci 2004 ; 223 : 113–119. [Google Scholar]
  51. Lyon G, Griscelli C, Fernandez-Alvarez E, et al. Chronic progressive encephalitis in children with x-linked hypogammaglobulinemia. Neuropédiatrie 1980 ; 11 : 57–71. [Google Scholar]
  52. Hara T, Yamashita S, Aiba H, et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000 ; 6 : 121–126. [Google Scholar]
  53. Dhib-Jalbut S, Jacobson S, McFarlin DE, McFarland HFImpaired measles-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann N Y Acad Sci 1988 ; 540 : 645–648. [Google Scholar]
  54. Memon SA, Afzal SS, Tukruna A, et al. Trends and Treatment of Sub-Acute Sclerosing Panencephalitis: An Updated Review. Glob Pediatr Health 2021; 8 : 2333794X211065330. [PubMed] [Google Scholar]
  55. Guler S, Kucukkoc M, Iscan APrognosis and demographic characteristics of SSPE patients in Istanbul. Turkey. Brain Dev 2015 ; 37 : 612–617. [Google Scholar]
  56. Griffin DEImmune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003 ; 3 : 493–502. [Google Scholar]
  57. Hernandez N, Bucciol G, Moens L, et al. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. J Exp Med 2019 ; 216 : 2057–2070. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.